Found: 23
Select item for more details and to access through your institution.
Breast density, benign breast disease, and risk of breast cancer over time.
- Published in:
- European Radiology, 2021, v. 31, n. 7, p. 4839, doi. 10.1007/s00330-020-07490-5
- By:
- Publication type:
- Article
Current controversies in the management of breast cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 4, p. 278, doi. 10.1007/s12094-010-0504-x
- By:
- Publication type:
- Article
Supportive care for patients with early breast cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 1, p. 32, doi. 10.1007/s12094-010-0464-1
- By:
- Publication type:
- Article
Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study).
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 4, p. 221, doi. 10.1007/s12094-009-0344-8
- By:
- Publication type:
- Article
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 12, p. 896, doi. 10.1007/s12094-006-0153-2
- By:
- Publication type:
- Article
Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 10, p. 755, doi. 10.1007/s12094-006-0123-8
- By:
- Publication type:
- Article
Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 3, p. 193, doi. 10.1007/s12094-006-0010-3
- By:
- Publication type:
- Article
A comparative study of HER2/neu amplification and overexpression using fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) in 101 breast cancer patients.
- Published in:
- Clinical & Translational Oncology, 2002, v. 4, n. 5, p. 255, doi. 10.1007/BF02732510
- By:
- Publication type:
- Article
Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 53, doi. 10.1007/s10549-019-05289-7
- By:
- Publication type:
- Article
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01544
- By:
- Publication type:
- Article
Thromboembolic, cardiovascular and overall mortality risks of aromatase inhibitors, compared with tamoxifen treatment: an outpatient-register-based retrospective cohort study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920909660
- By:
- Publication type:
- Article
Total Effective Xenoestrogen Burden in Serum Samples and Risk for Breast Cancer in a Population-Based Multicase-Control Study in Spain.
- Published in:
- Environmental Health Perspectives, 2016, v. 124, n. 10, p. 1575, doi. 10.1289/EHP157
- By:
- Publication type:
- Article
Eficacia y seguridad de una nueva formulación de enjuague bucal de dexametasona para el manejo de la estomatitis en pacientes con cáncer.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2021, v. 45, n. 1, p. 41, doi. 10.7399/fh.11460
- By:
- Publication type:
- Article
Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 140, n. 2, p. 385, doi. 10.1007/s10549-013-2638-3
- By:
- Publication type:
- Article
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 1159, doi. 10.1007/s10549-012-2013-9
- By:
- Publication type:
- Article
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 125, n. 3, p. 869, doi. 10.1007/s10549-010-1075-9
- By:
- Publication type:
- Article
Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 5, p. 291, doi. 10.1177/1758834015598536
- By:
- Publication type:
- Article
High Circulating HER2 Extracellular Domain Levels Correlate With Reduced Efficacy of an Aromatase Inhibitor in Hormone Receptor-positive Metastatic Breast Cancer: A Confirmatory Prospective Study.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 10, p. 2178, doi. 10.1002/cncr.23043
- By:
- Publication type:
- Article
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
- Published in:
- European Journal of Cancer Care, 2018, v. 27, n. 4, p. 1, doi. 10.1111/ecc.12861
- By:
- Publication type:
- Article
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
- Published in:
- Journal of Bone & Mineral Research, 2020, v. 35, n. 2, p. 291, doi. 10.1002/jbmr.3886
- By:
- Publication type:
- Article
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.
- Published in:
- Genome Medicine, 2018, v. 10, p. 1, doi. 10.1186/s13073-018-0531-8
- By:
- Publication type:
- Article